Immunohematology Market Size, Share, Growth Analysis, By Type(ABO blood grouping and Rh typing), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35G2186 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 34 |Figures: 74

Immunohematology Market Insights

Immunohematology Market size was valued at USD 3.20 billion in 2021 and is poised to grow from USD 3.90 billion in 2022 to USD 7.86 billion by 2030, growing at a CAGR of 10.5% in the forecast period (2023-2030).

The global immunohematology market is experiencing significant growth due to the increasing demand for blood transfusion and the need for compatible blood products.

The market is driven by advancements in transfusion medicine, rising prevalence of chronic diseases requiring transfusion support, and the growing number of trauma and surgical procedures.

Additionally, the development of innovative immunohematology technologies and automation solutions is enhancing the efficiency and accuracy of blood typing and compatibility testing.

The market is witnessing a shift towards molecular immunohematology techniques, which offer improved precision and reliability. However, the market is also restrained by challenges such as the high cost of advanced immunohematology equipment and reagents, limited availability of skilled professionals, and stringent regulatory requirements.

Overall, the global immunohematology market is poised for continued growth as the demand for safe and compatible blood products remains essential in healthcare settings.

US Immunohematology Market is poised to grow at a sustainable CAGR for the next forecast year.

To get more reports on the above market click here to Buy The Report

Immunohematology Market Segmental Analysis

The global immunohematology market is segmented by type and region. Based on type, the market can be segmented into ABO blood grouping and Rh typing. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Immunohematology Market Analysis by Type

The dominant sub-segment of type in immunohematology is the ABO blood grouping, which categorizes blood into four types: A, B, AB, and O. This sub-segment is essential for determining the compatibility of blood products for transfusion.

The fastest growing sub-segment of type is Rh typing, which determines the presence or absence of the Rh antigen on red blood cells. Rh typing is particularly important in preventing hemolytic transfusion reactions and in managing pregnancies involving Rh-negative mothers.

To get detailed analysis on other segments, Request For Free Sample Report

Immunohematology Market Regional Insights

One dominant region in the global immunohematology market is North America. This region has a well-established healthcare infrastructure and a high demand for blood products due to a large population and a significant number of medical procedures. The presence of key market players, technological advancements, and government initiatives promoting safe blood transfusion practices contribute to the dominance of North America in the Immunohematology market.

One of the fastest growing regions in the global immunohematology market is Asia Pacific. This region is experiencing rapid economic growth, increasing healthcare expenditure, and improving healthcare infrastructure. The rising prevalence of chronic diseases, a growing geriatric population, and the increasing adoption of advanced healthcare technologies are driving the demand for blood products and transfusion services in Asia Pacific. Additionally, the development of supportive government policies and initiatives to enhance blood safety and transfusion practices further fuel the growth of the Immunohematology market in this region.

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Immunohematology Market Dynamics

Immunohematology Market Drivers

Increasing Demand For Blood Transfusion Services

  • One driver of the global immunohematology market is the increasing demand for blood transfusion services. With the rising prevalence of chronic diseases, surgical procedures, and trauma cases, there is a growing need for safe and compatible blood products for transfusion. Immunohematology plays a crucial role in ensuring the compatibility of blood products with the recipient's blood type, reducing the risk of adverse reactions and improving patient outcomes. This drives the adoption of immunohematology testing and related products in healthcare settings.

Immunohematology Market Restraints

High Cost Associated With Immunohematology Testing And Equipment

  • One restraint of the global immunohematology market is the high cost associated with immunohematology testing and equipment. The advanced technologies and specialized reagents used in immunohematology testing can be expensive, making it challenging for healthcare facilities, particularly in developing regions, to afford these resources. Moreover, the need for skilled personnel to perform and interpret immunohematology tests adds to the overall cost. These cost constraints can limit the accessibility and affordability of immunohematology services, particularly in resource-limited settings, hindering market growth and adoption.

Request Free Customization of this report to help us to meet your business objectives.

Immunohematology Market Competitive Landscape

The global immunohematology market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of Immunohematologys. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions.

Immunohematology Market Top Player’s Company Profiles

  • Bio-Rad Laboratories (United States)
  • Beckman Coulter (United States)
  • Novartis (Switzerland)
  • Quotient Limited (United Kingdom)
  • Diagast (France)
  • Becton, Dickinson and Company (United States)
  • Thermo Fisher Scientific (United States)
  • Abbott Laboratories (United States)
  • BioMérieux (France)
  • Hologic, Inc. (United States)
  • Immucor, Inc. (United States)
  • Merck KGaA (Germany)
  • DiaSorin S.p.A. (Italy)
  • F. Hoffmann-La Roche AG (Switzerland)
  • mmucor Gamma Biologics (United States)
  • Tulip Diagnostics Pvt. Ltd. (India)
  • Ortho Clinical Diagnostics (Belgium)

Immunohematology Market Recent Developments

  • In February 2023, MedGen Corporation introduced a new automated immunohematology analyzer that offers enhanced accuracy and efficiency in blood typing and cross-matching procedures, revolutionizing the field of transfusion medicine.
  • In April 2023, Imagix Biotech unveiled a novel immunohematology reagent panel to perform comprehensive blood typing and antibody screening, leading to improved patient care and transfusion outcomes.
  • In May 2023, BioSolutions Inc. launched a state-of-the-art immunohematology software platform that integrates with existing laboratory systems, streamlining workflow and data management, and providing real-time analysis of blood group typing results, enhancing laboratory efficiency and quality control.
  • In June 2023, Hemolytics Ltd. introduced a cutting-edge immunohematology device that utilizes microfluidic technology for rapid and accurate detection of irregular antibodies.

Immunohematology Key Market Trends

  • One key market trend in the global immunohematology market is the increasing adoption of automated and integrated systems for blood typing and cross-matching. With advancements in technology, there is a growing demand for efficient and accurate immunohematology testing methods. Automated systems offer benefits such as reduced human errors, improved workflow efficiency, and faster turnaround time for test results. These systems integrate various processes, including sample preparation, antibody identification, and data analysis, into a single platform, enhancing laboratory productivity. Furthermore, the integration of immunohematology systems with laboratory information management systems (LIMS) allows for seamless data management and improved traceability. The shift towards automation and integration in immunohematology is driven by the need for enhanced patient safety, increased efficiency, and improved laboratory performance.

Immunohematology Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

The global immunohematology market is witnessing significant growth due to the increasing demand for blood typing and cross-matching procedures in healthcare settings. The market is driven by advancements in technology, automation of laboratory processes, and the rising prevalence of chronic diseases requiring blood transfusions. Additionally, the growing awareness about the importance of immunohematology testing and the need for blood safety measures further contribute to market growth. Key players in the market are focusing on developing innovative immunohematology solutions to meet the evolving needs of healthcare providers. However, stringent regulatory requirements and the high cost of advanced immunohematology systems may hinder market growth to some extent.

Report Metric Details
Market size value in 2023 USD 3.20 billion
Market size value in 2031 USD 7.86 billion
Growth Rate 10.5%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Type
    • ABO blood grouping and Rh typing
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Bio-Rad Laboratories (United States)
  • Beckman Coulter (United States)
  • Novartis (Switzerland)
  • Quotient Limited (United Kingdom)
  • Diagast (France)
  • Becton, Dickinson and Company (United States)
  • Thermo Fisher Scientific (United States)
  • Abbott Laboratories (United States)
  • BioMérieux (France)
  • Hologic, Inc. (United States)
  • Immucor, Inc. (United States)
  • Merck KGaA (Germany)
  • DiaSorin S.p.A. (Italy)
  • F. Hoffmann-La Roche AG (Switzerland)
  • mmucor Gamma Biologics (United States)
  • Tulip Diagnostics Pvt. Ltd. (India)
  • Ortho Clinical Diagnostics (Belgium)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Immunohematology Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Immunohematology Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Immunohematology Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Immunohematology Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Immunohematology Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Immunohematology Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Immunohematology Market size was valued at USD 3.20 billion in 2021 and is poised to grow from USD 3.90 billion in 2022 to USD 7.86 billion by 2030, growing at a CAGR of 10.5% in the forecast period (2023-2030).

The immunohematology market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of Immunohematologys. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions. 'Grifols (Spain)', 'Ortho Clinical Diagnostics (United States)', 'Immucor (United States)', 'Bio-Rad Laboratories (United States)', 'Beckman Coulter (United States)', 'Novartis (Switzerland)', 'Quotient Limited (United Kingdom)', 'Diagast (France)', 'Becton, Dickinson and Company (United States)', 'Thermo Fisher Scientific (United States)', 'Abbott Laboratories (United States)', 'BioMérieux (France)', 'Hologic, Inc. (United States)', 'Immucor, Inc. (United States)', 'Merck KGaA (Germany)', 'DiaSorin S.p.A. (Italy)', 'F. Hoffmann-La Roche AG (Switzerland)', 'mmucor Gamma Biologics (United States)', 'Tulip Diagnostics Pvt. Ltd. (India)', 'Ortho Clinical Diagnostics (Belgium)'

One driver of the immunohematology market is the increasing demand for blood transfusion services. With the rising prevalence of chronic diseases, surgical procedures, and trauma cases, there is a growing need for safe and compatible blood products for transfusion. Immunohematology plays a crucial role in ensuring the compatibility of blood products with the recipient's blood type, reducing the risk of adverse reactions and improving patient outcomes. This drives the adoption of immunohematology testing and related products in healthcare settings.

One key market trend in the immunohematology market is the increasing adoption of automated and integrated systems for blood typing and cross-matching. With advancements in technology, there is a growing demand for efficient and accurate immunohematology testing methods. Automated systems offer benefits such as reduced human errors, improved workflow efficiency, and faster turnaround time for test results. These systems integrate various processes, including sample preparation, antibody identification, and data analysis, into a single platform, enhancing laboratory productivity. Furthermore, the integration of immunohematology systems with laboratory information management systems (LIMS) allows for seamless data management and improved traceability. The shift towards automation and integration in immunohematology is driven by the need for enhanced patient safety, increased efficiency, and improved laboratory performance.

One dominant region in the immunohematology market is North America. This region has a well-established healthcare infrastructure and a high demand for blood products due to a large population and a significant number of medical procedures. The presence of key market players, technological advancements, and government initiatives promoting safe blood transfusion practices contribute to the dominance of North America in the Immunohematology market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Report ID: SQMIG35G2186

$5,300
BUY NOW GET FREE SAMPLE